Navigating the Drug Market Landscape

This chapter explores the intricate dynamics of drug market introduction, focusing on key stakeholders such as lawmakers and regulatory agencies. It emphasizes the contrasting viewpoints within Congress regarding healthcare policy and drug pricing, alongside the impact of pharmaceutical lobbying and advocacy efforts. Additionally, the role of venture capital in facilitating healthcare innovations is highlighted, showcasing the complex interplay between political, regulatory, and financial elements in the pharmaceutical sector.